| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/18/2001 | EP1115434A1 Adhesive protein foam for surgical and/or therapeutic uses |
| 07/18/2001 | EP1115423A1 Methods of downmodulating the immune response to therapeutic proteins |
| 07/18/2001 | EP1115421A2 Use of glp-1 or analogs in treatment of stroke |
| 07/18/2001 | EP1115420A2 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115417A2 Methods for administration of antibiotics |
| 07/18/2001 | EP1115416A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 07/18/2001 | EP1115415A1 Use of composition in the treatment of schizophrenia |
| 07/18/2001 | EP1115414A2 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 07/18/2001 | EP1115412A1 Neuroimmunophilins for selective neuronal radioprotection |
| 07/18/2001 | EP1115409A1 Composition for extending post meal satiety |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | EP1115397A1 Method of mitigating the adverse effects of interleukin-2 |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1115386A2 Treatment of infection |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP1115381A1 Proteinic drug delivery system using membrane mimetics |
| 07/18/2001 | EP1115380A2 Micronised pharmaceutical compositions |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP1115295A2 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
| 07/18/2001 | EP1115286A1 Methods for treating or preventing viral infections and associated diseases |
| 07/18/2001 | EP0949905B1 Injectable depot gel composition and method of preparing the composition |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | EP0846170B1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 07/18/2001 | EP0754048B1 Treatment of partial growth hormone insensitivity syndrome |
| 07/18/2001 | EP0742830B1 Fusion proteins that include antibody and nonantibody portions |
| 07/18/2001 | EP0681588A4 Max-interacting proteins and related molecules and methods |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |
| 07/18/2001 | CN1304451A Fusion proteins of i(mycobacterium tuberuculosis) antigens and their uses |
| 07/18/2001 | CN1304450A Novel insulin analogs with enhanced zinc binding |
| 07/18/2001 | CN1304449A Novel angiotensin receptor, production and use thereof |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304416A Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and use |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304315A Use of cyclosporins in treatment of inflammatory autoimmune diseases |
| 07/18/2001 | CN1303948A Method for secreting and expressing acid fibroblast growth factor |
| 07/18/2001 | CN1303946A Novel human ATP synthase and its code sequence |
| 07/18/2001 | CN1303945A Novel polypeptide-serine/threonine kinase 39 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303944A Novel polypeptide-threonine synthetase 71 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303943A Novel polypeptide-CoA carboxylase 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303942A Prawn white spot baculovirus genome DNA sequence and cDNA sequence |
| 07/18/2001 | CN1303939A Novel polypeptide-transcription factor 43 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303938A Novel polypeptide-human MATH37 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303937A Novel polypeptide-human tissue anion transport polypeptide 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303936A Novel polypeptide-zinc finger protein 56 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303934A Novel polypeptide-human Ra1BPI related protein 82 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303933A Novel polypeptide-human muscle BOP protein 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303932A Novel polypeptide-neurogenesis related protein 18 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303931A Novel polypeptide-XRN-100 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303930A Novel polypeptide-zinc finger protein 57 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303929A Novel polypeptide-robosomal protein 18 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303927A Novel polypeptide-steroid dehydrogenase 34 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303925A Novel polypeptide-arginyl tRNA synthetase 44 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303869A Egg yellow antiinterleukin -8 antibody, preparation method and its application |
| 07/18/2001 | CN1303867A New tumor inhibitor |
| 07/18/2001 | CN1303866A Novel polypeptide-zinc finger protein 36 and polynucleotide for coding this polypeptide |
| 07/18/2001 | CN1303865A Novel polypeptide-human vasicentric protein 69 and polynucleotide for coding said polypeptide |
| 07/18/2001 | CN1303864A Novel polypeptide-zinc finger protein 60 and polynucleotide for coding said polypeptide |
| 07/18/2001 | CN1303862A Novel polypeptide-human shearing and polyadenylation specific factor subunit 66 and polynucleotide for coding said polypeptide |
| 07/18/2001 | CN1303714A II type collagen oral gastric solubility preparation |
| 07/18/2001 | CN1303713A Health-care composition for preventing and curing radiation damage |
| 07/18/2001 | CN1303608A Production method of dietary collagenic animal and plant protein product |
| 07/18/2001 | CN1068586C Crystalline polymorphic form of (S.S.S)-N-(1-[2-carboxy-3-(N2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl) throsine |
| 07/18/2001 | CN1068524C Medicine for curing intractable psoriasis |
| 07/17/2001 | US6263040 Methods and apparatus for cone-tilted parallel sampling and reconstruction |
| 07/17/2001 | US6262336 Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter |
| 07/17/2001 | US6262335 Transgenic mice expressing APP mutant at amino acids 717, 721 and 722 |
| 07/17/2001 | US6262333 Human genes and gene expression products |
| 07/17/2001 | US6262253 Vitamin B12 conjugates with gcsf, analogues thereof and pharmaceutical compositions |
| 07/17/2001 | US6262247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/17/2001 | US6262245 Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262243 Nucleic acids encoding antimicrobial peptides |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6262241 Antisense compounds which cleave phosphorodiester bonds and improve pharmacodynamic and pharmacokinetic properties of oligonucleotides, useful in diagnosing diseases |
| 07/17/2001 | US6262239 TNF receptor-specific antibodies |
| 07/17/2001 | US6262237 Contacting protocadherin-encoding polynucleotide sequence with antibody (monoclonal, polyclonal, chimeric or humanized) antagonizes homophilic binding; useful for intercellular adhesion |
| 07/17/2001 | US6262236 Fibrin sealant compositions and methods for utilizing same |
| 07/17/2001 | US6262233 Tissue factor pathway inhibitor-3 |
| 07/17/2001 | US6262230 Stable, synthetic polypeptides (modifiers of production of alpha- and gamma-interferons, of macrophage migration inhibitory factor, and of expression of lymphocyte markers; use in treatment of endotoxicity in animals |
| 07/17/2001 | US6262228 Isolated interleukin-1 receptor associated kinase (irak3) polypeptides regulate cellular responsiveness to cytokine activation and play role in inflammatory responses and/or immune regulation |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262102 Eprosartan monohydrate |
| 07/17/2001 | US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease. |
| 07/17/2001 | US6262080 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/17/2001 | US6262069 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/17/2001 | US6262047 Selective factor Xa inhibitors |
| 07/17/2001 | US6262036 Method for inhibiting RNA translation using chimeric oligonucleoside compounds |
| 07/17/2001 | US6262035 Gene replacement therapy for muscular dystrophy |
| 07/17/2001 | US6262033 Remedy for diseases associated with NF-κB |
| 07/17/2001 | US6262032 Method of destroying hyperproliferative cells by combined p53 and taxoid treatment |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6262027 Reduction of impairment of respiratory tract mucosal immunity |
| 07/17/2001 | US6262026 Chimeric proteins for use in transport of a selected substance into cells |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |